142 related articles for article (PubMed ID: 12366669)
1. Tamoxifen-related uterine carcinosarcomas occur under/after prolonged treatment: report of five cases and review of the literature.
Kloos I; Delaloge S; Pautier P; Di Palma M; Goupil A; Duvillard P; Cailleux PE; Lhomme C
Int J Gynecol Cancer; 2002; 12(5):496-500. PubMed ID: 12366669
[TBL] [Abstract][Full Text] [Related]
2. [Uterine carcinosarcomas associated with tamoxifen therapy. Report of two cases and review of the literature].
Leung F; Terzibachian JJ; Govyadovskiy A; Bourtembourg A; Aouar Z; Fat BC; Maillet R; Riethmuller D
J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):173-8. PubMed ID: 19135318
[TBL] [Abstract][Full Text] [Related]
3. Carcinosarcoma arising in uterine didelphys after tamoxifen therapy for breast cancer: a case report.
Suprasert P; Khunamornpong S
J Med Assoc Thai; 2010 May; 93(5):608-12. PubMed ID: 20524448
[TBL] [Abstract][Full Text] [Related]
4. Uterine carcinosarcoma in association with tamoxifen therapy.
McCluggage WG; McManus DT; Lioe TF; Hill CM
Br J Obstet Gynaecol; 1997 Jun; 104(6):748-50. PubMed ID: 9197885
[No Abstract] [Full Text] [Related]
5. Ovarian carcinosarcomas associated with prolonged use of tamoxifen: case reports.
Lavie O; Longacre T; Segev Y; Husain A
Int J Gynecol Cancer; 2009 Dec; 19(9):1521-3. PubMed ID: 19955929
[TBL] [Abstract][Full Text] [Related]
6. Carcinosarcoma, endometrial intraepithelial carcinoma and endometriosis after tamoxifen therapy in breast cancer.
Friedrich M; Villena-Heinsen C; Mink D; Bonkhoff H; Schmidt W
Eur J Obstet Gynecol Reprod Biol; 1999 Jan; 82(1):85-7. PubMed ID: 10192492
[TBL] [Abstract][Full Text] [Related]
7. Long-term tamoxifen treatment: a possible aetiological factor in the development of uterine carcinosarcoma: two case-reports and review of the literature.
Fotiou S; Hatjieleftheriou G; Kyrousis G; Kokka F; Apostolikas N
Anticancer Res; 2000; 20(3B):2015-20. PubMed ID: 10928144
[TBL] [Abstract][Full Text] [Related]
8. Uterine sarcomas in breast cancer patients treated with tamoxifen.
Arenas M; Rovirosa A; Hernández V; Ordi J; Jorcano S; Mellado B; Biete A
Int J Gynecol Cancer; 2006; 16(2):861-5. PubMed ID: 16681774
[TBL] [Abstract][Full Text] [Related]
9. Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma.
Matsuo K; Ross MS; Bush SH; Yunokawa M; Blake EA; Takano T; Ueda Y; Baba T; Satoh S; Shida M; Ikeda Y; Adachi S; Yokoyama T; Takekuma M; Takeuchi S; Nishimura M; Iwasaki K; Yanai S; Klobocista MM; Johnson MS; Machida H; Hasegawa K; Miyake TM; Nagano T; Pejovic T; Shahzad MM; Im DD; Omatsu K; Ueland FR; Kelley JL; Roman LD
Gynecol Oncol; 2017 Feb; 144(2):329-335. PubMed ID: 27931750
[TBL] [Abstract][Full Text] [Related]
10. Uterine carcinosarcoma in association with tamoxifen therapy.
Oláh KS
Br J Obstet Gynaecol; 1997 Dec; 104(12):1420. PubMed ID: 9422027
[No Abstract] [Full Text] [Related]
11. Development of uterine sarcoma after tamoxifen treatment for breast cancer: report of four cases.
Yildirim Y; Inal MM; Sanci M; Yildirim YK; Mit T; Polat M; Tinar S
Int J Gynecol Cancer; 2005; 15(6):1239-42. PubMed ID: 16343223
[TBL] [Abstract][Full Text] [Related]
12. [The uterine sarcoma, a new risk identified for tamoxifen].
Baron M; Dessogne P; d'Anjou J
Presse Med; 2004 Mar; 33(5):321-2. PubMed ID: 15041879
[No Abstract] [Full Text] [Related]
13. Uterine carcinosarcoma related to tamoxifen.
McCluggage WG
Int J Gynecol Cancer; 2003; 13(5):697-8; author reply 697-8. PubMed ID: 14675359
[No Abstract] [Full Text] [Related]
14. High Incidence of Carcinosarcoma among Patients Previously Treated with Tamoxifen.
Segev Y; Arnon E; Siegler E; Gemer O; Goldberg Y; Auslender R; Kaldawy A; Lavie O
Isr Med Assoc J; 2017 Mar; 19(3):164-167. PubMed ID: 28457094
[TBL] [Abstract][Full Text] [Related]
15. [Uterine sarcoma in patients receiving tamoxifen therapy. Apropos of 2 cases].
Le Bouëdec G; Auvray H; Curé H; de Latour M; Penault-Llorca F; Dauplat J
Rev Med Interne; 2001 Sep; 22(9):881-5. PubMed ID: 11599191
[TBL] [Abstract][Full Text] [Related]
16. HER-2/neu oncogene in uterine carcinosarcoma on tamoxifen therapy.
Raspollini MR; Mecacci F; Paglierani M; Marchionni M; Taddei GL
Pathol Res Pract; 2005; 201(2):141-4. PubMed ID: 15901136
[TBL] [Abstract][Full Text] [Related]
17. Uterine sarcoma after tamoxifen therapy for breast cancer.
Samuji M; O'Sullivan R; Shireen R
Ir Med J; 2013 Sep; 106(8):246. PubMed ID: 24282897
[TBL] [Abstract][Full Text] [Related]
18. Myxoid leiomyosarcoma of the uterus in a patient receiving tamoxifen therapy: a case report.
Botsis D; Koliopoulos C; Kondi-Pafitis A; Creatsas G
Int J Gynecol Pathol; 2006 Apr; 25(2):173-5. PubMed ID: 16633068
[TBL] [Abstract][Full Text] [Related]
19. Uterine malignant mixed Müllerian tumor after adjuvant tamoxifen treatment for breast cancer.
Grigoriadis C; Androutsopoulos G; Zygouris D; Arnogiannaki N; Terzakis E
Eur J Gynaecol Oncol; 2013; 34(1):94-8. PubMed ID: 23590011
[TBL] [Abstract][Full Text] [Related]
20. Uterine malignancy following tamoxifen use in breast cancer patients in Iran: case series and literature review.
Behtash N; Hashemi R; Karimi Zarchi M
Asian Pac J Cancer Prev; 2009; 10(1):163-6. PubMed ID: 19469647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
